Atlas Trials

A Phase 1b Study to Evaluate APL-1401 in Patients With Moderately to Severely Active Ulcerative Colitis

Clinical trial NCT05743010 · UNKNOWN

Trial details

NCT number
NCT05743010
Sponsor
Jiangsu Yahong Meditech Co., Ltd aka Asieris
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Ulcerative Colitis
Start date
2023-01-26
Primary completion
2025-03-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.